China Pharma Holdings (CPHI) Accumulated Depreciation & Amortization: 2010-2025
Historic Accumulated Depreciation & Amortization for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to $33.0 million.
- China Pharma Holdings' Accumulated Depreciation & Amortization rose 1.10% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.0 million, marking a year-over-year increase of 3.58%. This contributed to the annual value of $32.1 million for FY2024, which is 5.61% up from last year.
- Per China Pharma Holdings' latest filing, its Accumulated Depreciation & Amortization stood at $33.0 million for Q3 2025, which was up 1.23% from $32.6 million recorded in Q2 2025.
- In the past 5 years, China Pharma Holdings' Accumulated Depreciation & Amortization ranged from a high of $33.0 million in Q3 2025 and a low of $26.1 million during Q2 2021.
- Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $31.5 million (2024), whereas its average is $31.2 million.
- Data for China Pharma Holdings' Accumulated Depreciation & Amortization shows a peak YoY increased of 22.77% (in 2021) over the last 5 years.
- Quarterly analysis of 5 years shows China Pharma Holdings' Accumulated Depreciation & Amortization stood at $28.2 million in 2021, then climbed by 0.68% to $28.4 million in 2022, then rose by 7.21% to $30.4 million in 2023, then grew by 5.61% to $32.1 million in 2024, then increased by 1.10% to $33.0 million in 2025.
- Its Accumulated Depreciation & Amortization was $33.0 million in Q3 2025, compared to $32.6 million in Q2 2025 and $32.3 million in Q1 2025.